REFERENCES
- Spencer , C. M. ; Faulds , D. ; Peters , D. H. Cetirizine: A Reappraisal of Its Pharmacological Properties and Therapeutic Use in Selected Allergic Disorders . Drugs 1993 , 46 , 1055 – 1080 .
- The Merck Index. An Encyclopedia of Chemical, Drugs and Biologicals, , 13th ed. ; Merck Research Laboratories, Division of Merck & Co Inc. : Whitehouse Station , NJ , 2001 , pp. 346 – 347 .
- Rudaz , S. ; Souverain , S. ; Schelling , C. ; Deleers , M. ; Klomp , A. ; Norris , A. ; Vu , T. L. ; Ariano , B. ; Veuthey , J. L. Development and Validation of a Heart-Cutting Liquid Chromatography-Mass Spectrometry Method for the Determination of Process-Related Substances in Cetirizine Tablets . Anal. Chim. Acta. 2001 , 492 , 271 – 282 .
- Jaber , A. M. Y. ; Al Sherife , H. A. ; Al Omari , M. M. ; Badwan , A. A. Determination of Cetirizine Dihydrochloride, Related Impurities and Preservatives in Oral Solution and Tablet Dosage Forms Using HPLC . J. Pharm. Biomed. Anal. 2004 , 36 , 341 – 350 .
- Yu , H. ; Cornett , C. ; Larsen , J. ; Hansen , S. H. Reaction Between Drug Substances and Pharmaceutical Excipients: Formation of Esters Between Cetirizine and Polyols . J. Pharm. Biomed. Anal. 2010 , 53 , 745 – 750 .
- Zajac , M. ; Musia , A. W. ; Jeli , A. ; Ska , A. ; Stanisz , B. Stability of Cetirizine Dihydrochloride in Solid State . Acta Pol. Pharm. 2001 , 58 ( 1 ), 21 – 3 .
- British Pharmacopoeia Commission. British Pharmacopoeia , Stationary Office Books : Great Britain , 2003 , pp. 400 – 401 .
- El Walily , A. F. ; Korany , M. A. ; El-Gindy , A. ; Bedair , M. F. Spectrophotometric and High Performance Liquid Chromatographic Determination of Cetirizine Dihydrochloride in Pharmaceuticals Tablets . J. Pharmacol. Biomed. Anal. 1996 , 17 ( 3 ), 435 – 442 .
- Jeli , A. ; Ska , A. ; Stanisz , B. ; Zajac , M. ; Musia , A. W. ; Ostrowicz , A. Determination of Cetirizine in Tablet by HPLC Method . Acta. Pol. Pharm. 2000 , 57 ( 3 ), 171 – 173 .
- ICH. Validation of Analytical Procedure: Text Methodology , U.S Food and Drug Administration, IFPMA : Geneva , 2005 .
- ICH. 3QA Impurities in New Drug Substances , U.S Food and Drug Administration, IFPMA : Geneva , 2008 .
- ICH. 3QB Impurities in New Drug Substances , U.S Food and Drug Administration, IFPMA : Geneva , 2006 .